** Shares of India's Blue Jet Healthcare BLUJ.NS on course for their steepest 2-day percent decline since listing in November 2023
** Stock down 5% to 860 rupees on Wednesday, after falling 10% in the previous session
** Declines triggered by sequential qtrly profit drop, gross margin contracts to 48.4% from 54.7% Q/Q
** Pharma co's core profit undershot expectations on account of sharp Q/Q gross margin decline amid reduction of inventory levels - Emkay Research
** Brokerage says it is moderating gross margin assumptions for FY26, FY27; cuts TP to 1,050 rupees from 1,150 rupees
** Stock, rated "buy" by Emkay, is also rated "buy" on avg; with median TP at 965 rupees - data compiled by LSEG
** Stock up 52% YTD
(Reporting by Hritam Mukherjee in Bengaluru)
((Hritam.Mukherjee@thomsonreuters.com;))